Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
BioRegenx Reports Improved Net Loss of $26,415 Amid Revenue Decline
BioRegenx Reports 21% Decline in Net Sales, Significant Improvement in Net Loss for Fiscal Year 2025
BioRegenx Reports Improved Net Loss of $80,565 in Q3 2025 Amid Sales Decline
BioRegenx Reports 39% Decline in Q2 2025 Net Sales, Seeks Additional Financing
BioRegenx Reports Decline in Sales, Improvement in Profitability in Latest 10-Q Filing
BioRegenx Reports Significant Financial Challenges, Net Loss Increases 417% in Latest Quarter